Page last updated: 2024-08-25

zoledronic acid and Atrial Fibrillation

zoledronic acid has been researched along with Atrial Fibrillation in 21 studies

Research

Studies (21)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	9 (42.86)	29.6817
2010's	8 (38.10)	24.3611
2020's	4 (19.05)	2.80

Authors

Authors	Studies
Cromer, SJ; D'Silva, KM; Fischer, M; Kim, SC; Yu, EW	1
Arnaud, L; Javier, RM; Lebrun-Vignes, B; Pijnenburg, L; Salem, JE; Sibilia, J	1
He, B; Quan, ZX; Zhang, MZ; Zhao, JQ	1
Li, Y; Lin, J; Wang, P; Xie, Y; Xu, H; Yao, X; Zhuang, H	1
Aksoy, S; Arik, Z; Demir, M; Eren, T; Ozdemir, N; Sendur, MA; Ucar, O; Uncu, D; Yaman, S; Yazici, O; Zengin, N	1
Bournia, VK; Dania, V; Iliopoulos, A; Konsta, M	1
Aktaş, İ; Çincin, A; Doğan Metin, F; Erdoğan, O; İlgezdi, ZD; Kepez, A; Kıvrak, T; Şilte, AD; Ünlü Özkan, F; Yılmaz Kaysın, M	1
Allen, MR; Jaynes, HA; Kovacs, RJ; Overholser, BR; Tisdale, JE	1
Fulchino, LA; Kim, CA; Kim, DH; Kim, SC; Rogers, JR; Solomon, DH	1
Akpinar, P; Aktas, I; Dogan, Z; Erdogan, O; Ileri, C; Kaysin, MY; Kepez, A; Nazikoglu, C; Ozkan, FU; Saymaz, S	1
Ringe, JD	1
Aksoy, S; Altundag, K; Arslan, C; Dede, DS; Dizdar, O; Harputluoglu, H	1
John Camm, A	1
Black, DM; Boonen, S; Caminis, J; Cauley, JA; Cosman, F; Cummings, SR; Delmas, PD; Eastell, R; Eriksen, EF; Hu, H; Hue, TF; Krasnow, J; Lakatos, P; Leung, PC; Man, Z; Mautalen, C; Mesenbrink, P; Reid, IR; Rosario-Jansen, T; Sellmeyer, D; Tong, K	1
Black, DM; Cummings, SR; Schwartz, AV	1
Geusens, PP; Lems, WF	1
de Nijs, RN; Westgeest, AA	1
Camm, J; Karam, R; McClung, M	1
Kaptoge, S; Poole, KE; Reeve, J	1
Zuber, MA	1
Lopez, CA; Tasneem, Z	1

Reviews

4 review(s) available for zoledronic acid and Atrial Fibrillation

Article	Year
Atrial fibrillation in patients treated with intravenous zoledronic or pamidronic acid: a pharmacoepidemiological study. European journal of endocrinology, 2021, Volume: 184, Issue:3 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Atrial Fibrillation; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Europe; Female; Humans; Male; North America; Pamidronate; Pharmacoepidemiology; Pharmacovigilance; World Health Organization; Zoledronic Acid	2021
Zoledronic acid and fracture risk: a meta-analysis of 12 randomized controlled trials. European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:3 Topics: Atrial Fibrillation; Bone Density; Bone Density Conservation Agents; Fractures, Bone; Humans; Randomized Controlled Trials as Topic; Zoledronic Acid	2021
Bisphosphonates and risk of cardiovascular events: a meta-analysis. PloS one, 2015, Volume: 10, Issue:4 Topics: Atrial Fibrillation; Bone Density Conservation Agents; Cardiovascular Diseases; Databases, Factual; Diphosphonates; Follow-Up Studies; Humans; Imidazoles; Myocardial Infarction; Odds Ratio; Osteoporosis; Risk; Stroke; Zoledronic Acid	2015
Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis. Clinical therapeutics, 2010, Volume: 32, Issue:3 Topics: Animals; Atrial Fibrillation; Bone Density Conservation Agents; Cardiovascular Diseases; Diphosphonates; Female; Humans; Imidazoles; Osteoporosis; Randomized Controlled Trials as Topic; Risk; Zoledronic Acid	2010

Trials

2 trial(s) available for zoledronic acid and Atrial Fibrillation

Article	Year
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. The New England journal of medicine, 2007, May-03, Volume: 356, Issue:18 Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; Bone Density; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Drug Administration Schedule; Female; Fractures, Bone; Hip Fractures; Humans; Imidazoles; Incidence; Infusions, Intravenous; Osteoporosis, Postmenopausal; Risk; Spinal Fractures; Zoledronic Acid	2007
[Fracture prevention in postmenopausal women with osteoporosis by an annual infusion of zoledronic acid]. Nederlands tijdschrift voor geneeskunde, 2007, Jun-30, Volume: 151, Issue:26 Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Bone Density; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Hip Fractures; Humans; Imidazoles; Infusions, Intravenous; Osteoporosis, Postmenopausal; Spinal Fractures; Treatment Outcome; Zoledronic Acid	2007

Article

Year

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

The New England journal of medicine, 2007, May-03, Volume: 356, Issue:18

Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; Bone Density; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Drug Administration Schedule; Female; Fractures, Bone; Hip Fractures; Humans; Imidazoles; Incidence; Infusions, Intravenous; Osteoporosis, Postmenopausal; Risk; Spinal Fractures; Zoledronic Acid

2007

[Fracture prevention in postmenopausal women with osteoporosis by an annual infusion of zoledronic acid].

Nederlands tijdschrift voor geneeskunde, 2007, Jun-30, Volume: 151, Issue:26

Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Bone Density; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Hip Fractures; Humans; Imidazoles; Infusions, Intravenous; Osteoporosis, Postmenopausal; Spinal Fractures; Treatment Outcome; Zoledronic Acid

2007

Other Studies

15 other study(ies) available for zoledronic acid and Atrial Fibrillation

Article	Year
Risk of Incident Atrial Fibrillation With Zoledronic Acid Versus Denosumab: A Propensity Score-Matched Cohort Study. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2021, Volume: 36, Issue:1 Topics: Atrial Fibrillation; Bone Density Conservation Agents; Cohort Studies; Denosumab; Female; Humans; Propensity Score; Zoledronic Acid	2021
A Single-Center Prospective Study of 116 Women with Osteoporosis Treated with Zoledronic Acid Monitored by Electrocardiography for the Development of Cardiac Arrhythmia During the Acute Phase in China. Medical science monitor : international medical journal of experimental and clinical research, 2021, Mar-12, Volume: 27 Topics: Acute Disease; Aged; Arrhythmias, Cardiac; Asian People; Atrial Fibrillation; Diphosphonates; Electrocardiography; Female; Heart Atria; Heart Rate; Humans; Middle Aged; Monitoring, Physiologic; Osteoporosis; Prospective Studies; Zoledronic Acid	2021
Arrhythmias during and after zoledronic acid infusion patients with bone metastasis. Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:3 Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Bone Neoplasms; Diphosphonates; Female; Heart Ventricles; Humans; Imidazoles; Male; Middle Aged; Zoledronic Acid	2013
Atrial fibrillation following intravenous zolendronic acid for osteoporosis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2014, Volume: 20, Issue:4 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Atrial Fibrillation; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Osteoporosis; Retrospective Studies; Zoledronic Acid	2014
Acute effect of zoledronic acid infusion on atrial fibrillation development in patients with osteoporosis. Anatolian journal of cardiology, 2015, Volume: 15, Issue:4 Topics: Atrial Fibrillation; Diphosphonates; Echocardiography; Electrocardiography, Ambulatory; Female; Hip Fractures; Humans; Imidazoles; Infusions, Intravenous; Middle Aged; Osteoporosis, Postmenopausal; Zoledronic Acid	2015
Influence of Zoledronic Acid on Atrial Electrophysiological Parameters and Electrocardiographic Measurements. Journal of cardiovascular electrophysiology, 2015, Volume: 26, Issue:6 Topics: Action Potentials; Animals; Atrial Fibrillation; Bone Density Conservation Agents; Diphosphonates; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Female; Guinea Pigs; Imidazoles; Perfusion; Risk; Zoledronic Acid	2015
Effect of intravenous zoledronic acid infusion on electrocardiographic parameters in patients with osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2016, Volume: 27, Issue:12 Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Bone Density Conservation Agents; Diphosphonates; Electrocardiography; Female; Humans; Imidazoles; Male; Osteoporosis; Zoledronic Acid	2016
[Atrial fibrillation during bisphosphonate therapy. side effects or coincidental finding?]. MMW Fortschritte der Medizin, 2009, Mar-05, Volume: 151, Issue:10 Topics: Alendronate; Atrial Fibrillation; Bone Density Conservation Agents; Clinical Trials as Topic; Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Osteoporosis, Postmenopausal; Retrospective Studies; Zoledronic Acid	2009
Zoledronic acid and atrial fibrillation in cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Electrocardiography; Female; Humans; Imidazoles; Male; Middle Aged; Neoplasms; Risk Factors; Smoking; Zoledronic Acid	2011
Alendronate and atrial fibrillation. The New England journal of medicine, 2007, May-03, Volume: 356, Issue:18 Topics: Aged; Alendronate; Atrial Fibrillation; Bone Density Conservation Agents; Diphosphonates; Female; Fractures, Bone; Humans; Imidazoles; Osteoporosis, Postmenopausal; Zoledronic Acid	2007
Yearly zoledronic acid in postmenopausal osteoporosis. The New England journal of medicine, 2007, Aug-16, Volume: 357, Issue:7 Topics: Atrial Fibrillation; Bone Density Conservation Agents; Calcium; Diphosphonates; Drug Administration Schedule; Female; Fractures, Bone; Humans; Hypocalcemia; Imidazoles; Osteoporosis, Postmenopausal; Parathyroid Hormone; Zoledronic Acid	2007
Yearly zoledronic acid in postmenopausal osteoporosis. The New England journal of medicine, 2007, Aug-16, Volume: 357, Issue:7 Topics: Administration, Oral; Aged; Alendronate; Atrial Fibrillation; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Imidazoles; Osteoporosis, Postmenopausal; Risedronic Acid; Zoledronic Acid	2007
Yearly zoledronic acid in postmenopausal osteoporosis. The New England journal of medicine, 2007, Aug-16, Volume: 357, Issue:7 Topics: Atrial Fibrillation; Bone Density Conservation Agents; Calcium; Diphosphonates; Female; Fractures, Bone; Humans; Hypocalcemia; Imidazoles; Osteoporosis, Postmenopausal; Parathyroid Hormone; Zoledronic Acid	2007
[Osteoporosis and bisphosphonates]. Zeitschrift fur Rheumatologie, 2007, Volume: 66, Issue:8 Topics: Aged; Alendronate; Atrial Fibrillation; Bone Density Conservation Agents; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Imidazoles; Infusions, Intravenous; Middle Aged; Multicenter Studies as Topic; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Risk Assessment; Zoledronic Acid	2007
Zoledronate, fractures, and mortality after hip fracture. The New England journal of medicine, 2008, Feb-28, Volume: 358, Issue:9 Topics: Atrial Fibrillation; Bone Density Conservation Agents; Confounding Factors, Epidemiologic; Diphosphonates; Fractures, Bone; Hip Fractures; Humans; Imidazoles; Zoledronic Acid	2008